News

bjo.bmj1d
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes
Background/Aim To assess visual acuity (VA) outcomes and antivascular endothelial growth factor (anti-VEGF) treatment intensity in diabetic macular oedema (DMO). Methods Retrospective analysis was ...
bjo.bmj1d
Postoperative infection in penetrating versus non-penetrating glaucoma surgery
Correspondence to Dr Tarek Shaarawy, Department of Ophthalmology, University Hospital of Geneva, 22 rue Alcide Jentzer, 1211 Geneva 14, Switzerland; tarek.shaarawy{at}hcuge.ch The aim of glaucoma ...
bjo.bmj2d
Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke
Aims We examine whether inclusion of artificial intelligence (AI)-enabled retinal vasculometry (RV) improves existing risk algorithms for incident stroke, myocardial infarction (MI) and circulatory ...
bjo.bmj3d
Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis: implications for aetiology and early prevention
The aim of this review was to quantify the global variation in childhood myopia prevalence over time taking account of demographic and study design factors. A systematic review identified ...
bjo.bmj3d
Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study
Correspondence to Dr John Olson, Grampian Retinal Screening Programme, David Anderson Building, Foresterhill Road, Aberdeen, AB25 2ZP, UK; john.olson{at}nhs.net Background/aims Retinal screening ...
bjo.bmj6d
The evaluation and surgical management of cyclodialysis clefts that have failed to respond to conservative management
Purpose To investigate factors that may influence successful correction of hypotony in a consecutive series of patients with cyclodialysis clefts repaired surgically over a 10-year period. Design ...
bjo.bmj7d
Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review
Correspondence to Maurizio Rolando, Ocular Surface Unit, ISPRE Genova, Genoa, Italy; maurizio.rolando{at}gmail.com Dry eye disease (DED) is a growing public health concern affecting quality of life ...
bjo.bmj8d
Comparison of biometric and refractive changes in intermittent exotropia with and without overminus lens therapy
Background Overminus lens is an effective non-surgical treatment of intermittent exotropia (IXT). Whether this treatment causes development of myopia is recently debated. This study evaluated ocular ...
bjo.bmj9d
One-year myopia control efficacy of spectacle lenses with aspherical lenslets
Aims To evaluate the 1-year efficacy of two new myopia control spectacle lenses with lenslets of different asphericity. Methods One hundred seventy schoolchildren aged 8–13 years with myopia of −0.75 ...
bjo.bmj9d
Keratoscope-guided opening of graft-host junction to treat elevated astigmatism after deep anterior lamellar keratoplasty
Aims To describe a simple surgical technique consisting of opening the vertical graft-host junction (GHJ) to manage high astigmatism following deep anterior lamellar keratoplasty (DALK) and to report ...
bjo.bmj10d
Release of silicone oil and the off-label use of syringes in ophthalmology
Background/aims To assess silicone oil (SO) release by different brands of syringes used for intravitreal injection under different handling conditions. Methods Eight syringes were analysed: from the ...
bjo.bmj11d
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
Background The 0.2 µg/day fluocinolone acetonide (FAc) implant delivers continuous, low-dose, intravitreal corticosteroid for the treatment of diabetic macular oedema (DMO). This ongoing, 3-year, ...